BlackRock’s Oculis Holding OCS Stock Holding History

BlackRock’s Portfolio OCS Stock Details OCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11.8K	Buy	+1,266	New	+$15.1K	﹤0.01%	5540

Other funds holding OCS

EQT Fund Management Luxembourg $947M AUM 19.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor San Francisco, California $252M AUM 45.72% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $126B AUM 27.87% 1-Year Est. Return

Syquant Capital SAS Paris, France $453M AUM 6.35% 1-Year Est. Return

Nan Fung Group Holdings Kai Tak, Hong Kong $150M AUM 39.16% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

BlackRock's OCS Position: Q3 2026 in Review

BlackRock opened a new position in Oculis Holding (OCS) in Q3 2026: 1,266 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #5540 among its holdings.

39 funds tracked by Wall St. Rank hold OCS as of Q3 2026.

BlackRock held 1,266 shares of Oculis Holding worth $11.8K as of Q3 2026.
Oculis Holding was a new BlackRock position in Q3 2026.
Oculis Holding made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #5540 holding.
39 funds tracked by Wall St. Rank held Oculis Holding as of Q3 2026.

Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.